PCAS Finland
Contract manufacturer of active pharmaceutical ingredients and advanced intermediates for pharma companies, from Turku, Finland
Highlights
- New on EvolcAdded 2026-11-02
About PCAS Finland
PCAS Finland Oy develops and manufactures active pharmaceutical ingredients (APIs) and advanced intermediates, as a fine chemicals company. Operations are carried out in an FDA-inspected cGMP plant.
The company serves the pharmaceutical industry. It is the Finnish subsidiary of PCAS S.A. of France.
PCAS Finland Oy was founded on 2001-02-02 and is headquartered in Turku, Finland.
Product: Development and manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates.
Jobs at PCAS Finland
More biotech & pharma companies
Pharmamile
Marketing, sales and consulting for veterinary medicines and feed supplements, serving animal health industry players in FinlandYoung companyNew on EvolcPharmatest Services
Preclinical contract research in oncology and musculoskeletal disease models for pharma and biotech drug developersNew on EvolcPharmatory
Contract development and cGMP manufacturing of small-molecule APIs for human and veterinary pharma companiesNew on EvolcPolku Therapeutics
Develops small-molecule therapies for neurodegenerative diseases by targeting tau aggregation and neuroinflammationYoung companyNew on EvolcPrecisionPhage
Phage genome bioinformatics software, lab services and a phage library for AMR and phage therapy researchYoung companyNew on EvolcPrimoceler
Hermetic glass packaging and laser bonding for active implantable device electronics, from prototype to series productionNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- LiteSpeedHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.